Macroeconomic uncertainties could impact spending in academia and biopharma.

For the quarter ended December 2024, 10x Genomics (TXG) reported revenue of $165.02 million, down 10.3% over the same period last year. EPS came in at -$0.40, compared to -$0.41 in the year-ago ...

Genomics (TXG) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.41 per share a year ago. These figures are adjusted ...

Reports Q4 revenue $165.0M, consensus $164.98M. “In 2024, we launched major new products across all three of our platforms and we made changes ...

PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Wednesday reported a loss of $49 million in its fourth quarter. The Pleasanton, California-based company said it had a ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

Strategic acquisitions, such as 10x Genomics acquiring ReadCoor and Cartana, are common to expand capabilities in spatial genomics and transcriptomics. Numerous startups, such as Resolve Biosciences ...

The Dassault Falcon 10X is a long-range business jet that is being developed by French aircraft manufacturer, Dassault Aviation. It was expected that certification and development will take place ...